Log in to save to my catalogue

Development of a highly effective combination monoclonal antibody therapy against Herpes simplex vir...

Development of a highly effective combination monoclonal antibody therapy against Herpes simplex vir...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_90dc32068a724229a0d3541e5d8a5ec7

Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus

About this item

Full title

Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus

Publisher

England: BioMed Central Ltd

Journal title

Journal of biomedical science, 2024-05, Vol.31 (1), p.56-56, Article 56

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Infections with Herpes simplex virus (HSV)-1 or -2 usually present as mild chronic recurrent disease, however in rare cases can result in life-threatening conditions with a large spectrum of pathology. Monoclonal antibody therapy has great potential especially to treat infections with virus resistant to standard therapies. HDIT101, a humanized IgG...

Alternative Titles

Full title

Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_90dc32068a724229a0d3541e5d8a5ec7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_90dc32068a724229a0d3541e5d8a5ec7

Other Identifiers

ISSN

1423-0127,1021-7770

E-ISSN

1423-0127

DOI

10.1186/s12929-024-01045-2

How to access this item